Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
91
天
Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis
作者
Elias Seidl; Andrew Zikic; Srdjan Micic; Rianne de Vries; Julie Avolio; Alexander Moeller; Felix Ratjen; Hartmut Grasemann展开收起
作者单位
Department of Respiratory Medicine, University Children's Hospital Zurich, Zurich, Switzerland; Division of Respiratory Medicine, Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada; Breathomix BV, Bargelaan 200, Leiden, CW 2333, The Netherlands; Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, ON M5G 1 × 8, Canada and University of Toronto, Toronto, Canada展开收起
225
天
Apical hyperosmotic challenge upregulates aquaporin-3 in human airway epithelia
作者
Alexander Sauter; Oliver H Wittekindt; Lara Gutjahr; Ronja Rössel; Manfred Frick; Sebastian FN Bode; Hanna Schmidt展开收起
作者单位
Institute of General Physiology, Ulm University; Albert-Einstein-Allee 11 89075, Ulm, Germany; Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center; Eythstraße 24 89075, Ulm, Germany展开收起
40
天
Microbiological outcomes associated with Burkholderia species in people with cystic fibrosis receiving CFTR modulator therapy
作者
Timothy Riddles; Daniel Smith; David W Reid; Daniel Henderson; Arianne J Blanco; Vanessa Moore; Michelle Wood; Ieuan E S Evans展开收起
作者单位
Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Brisbane, QLD, Australia; Faculty of Medicine, University of Queensland, QLD, Brisbane, Australia; Lung Inflammation & Infection, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia; Department of Microbiology, Royal Brisbane Women’s Hospital, Brisbane, QLD, Australia展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
